C100 FM

We began this podcast series by exploring the behavioural and perceptual effects this pandemic has had on us and what will be the lasting impact. We learned that changes will actually come slowly, but the changes will be long lasting – perhaps even generational.   We’ve learned that the future of work is no longer about working from home. It’s now about living at work.   We’ve learned that our behaviour drives outcomes. Physical distancing, wearing masks, sneezing into our elbows are behviours that determine whether we’re fighting the curve, flattening the curve or crushing the curve.   We’ve also learned that our expectations of government and corporations are framed by their behaviour. How have our leaders responded to your needs? How have corporations and brands addressed my concerns about your safety and your well-being?   How has COVID-19 changed the language of business and brands? How has it moved the messaging?   Graeme Newell is President of 602 Communications and an expert in DECISION SCIENCE. He joins us from his studio in Portland, Oregon. He says things haven't really changed. In fact, we've simply reverted to a more primitive, instinctive means of communication.

We know there will be a second wave of COVID-19. And it’s likely to hit us before the end of this calendar year. We also know that some countries, like Canada, have managed to crush the curve. Still, there are regions of the world where the curve continues to rise – particularly in Brazil, India and the United States. So, the daily news can be exhausting at best and grim when we consider the worst case scenarios. But there is some reason for optimism. Four months into the pandemic and more than 6 months after this strain of the coronavirus was first detected in China, the World Health Organization says there are currently 147 COVID-19 vaccines in development. At least 17 are now into the human trial phase. One of them is being developed in Australia. Professor Nikolai Petrovsky is the Chairman of the company called VAXINE Pty.  He says their results to date are more than promising.

Some good news, if not great news, on the research front. There are 147 COVID-19 vaccines in development and 17 of them are into the human trials. Professor Nikolai Petrovsky is the chairman of VAXINE – an Australian based company that is undertaking an international effort to develop a COVID 19 vaccine.  He and his team started human trials on July 1st, 2020